Healthequity Inc earnings beat by $0.04, revenue topped estimates. HealthEquity, Inc. (NASDAQ:HQY – Get Rating) was the recipient of a significant drop in short interest during the month of October. As of October 31st, there was short interest totalling 3,550,000 shares, a drop of 10.1% from the October 15th total of 3,950,000 shares. Approximately 4.3% of the shares of the company are short sold. Based on an average trading volume of 743,500 shares, the days-to-cover ratio is presently 4.8 days.

HealthEquity, Inc. (NASDAQ:HQY – Get Rating) – Investment analysts at Zacks Research increased their Q1 2024 earnings per share (EPS) estimates for HealthEquity in a report issued on Tuesday, November 15th. Zacks Research analyst D. Dey now forecasts that the company will post earnings per share. Healthequity Inc (HQY) is around the top of the Healthcare sector according to InvestorsObserver.
HQY receive. Market for health savings and related accounts is expected to see sizable growth, which bodes well for HQY long-term. Click here to read why we are hold for this stock now.The 45 rating InvestorsObserver gives to Ontrak Inc (OTRK) stock puts it near the top of the.

HealthEquity (NASDAQ:HQY) shareholder returns have been favorable, earning 43% in 5 years

Stock pickers are generally looking for stocks that will outperform the broader market. And while active stock picking. HealthEquity (HQY) is trading 3.2% higher after the company reported better-than-expected Q2 revenue and raised its full year revenue forecast. The company now expects revenues of $834M. 2022 Devenir Mid-Year HSA report establishes HealthEquity as the leading HSA administrator in assets and accountsDRAPER, Utah, Nov. 01, 2022 (GLOBE NEWSWIRE) — HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity”), the leader in health savings accounts (HSAs) and consumer-directed benefits administration, is ranked #1 in market share in a new independent report, capping 20 years of market-leading innovation and service. To mark the occasion, the Company has released a new edition of its renowned HS.

. Researching HealthEquity? Get The Latest HQY Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.

During September, there was a meteoric increase in the number of short positions held in HealthEquity, Inc. (NASDAQ: HQY). There were 4,310,000 shares. Researching HealthEquity? Get The Latest HQY Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.Image Source: FreeImages New year, new you…right? Although it seems like resolutions usually only last until the end of January, we think it’s important.

Homology Medicines (FIXX) Reports Q3 Loss, Misses Revenue Estimates

Homology Medicines (FIXX) delivered earnings and revenue surprises of -25.53% and 23.62%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?. Investors continue to be optimistic about Accuray (ARAY) owing to its solid global reach.AlerisLife ( NASDAQ:ALR ) Third Quarter 2022 Results Key Financial Results Revenue: US$182.7m (up 326% from 3Q 2021. Fulgent Genetics ( NASDAQ:FLGT ) Third Quarter 2022 Results Key Financial Results Revenue: US$105.7m (down 54% from 3Q.